{"Lopinavir":{"RelatedTo":["HIV-1 protease","Gag-Pol polyprotein"],"Synonym":["ABT-378","LPV","Aluviran"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB01601","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB01601","Definition":"Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is marketed by Abbott as Kaletra, a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV\/AIDS. Pharmacology: Lopinavir is an antiretroviral of the protease inhibitor class. Mechanism of action: Lopinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. Drug type: Approved. Small Molecule. Drug category: Anti-HIV Agents. HIV Protease Inhibitors"}}